Combination therapy with cisplatin: Modulation of activity and tumour sensitivity

H. J. Guchelaar; D. R.A. Uges; E. G.E. de Vries; J. W. Oosterhuis; N. H. Mulder

doi:10.1016/S0936-6555(05)81134-3

Combination therapy with cisplatin: Modulation of activity and tumour sensitivity

H. J. Guchelaar, D. R.A. Uges, E. G.E. de Vries, J. W. Oosterhuis, N. H. Mulder

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel recenseren › peer review

11 Citaten (Scopus)

Samenvatting

Although cisplatin is applied with success in clinical oncology, this success is limited because some cancers are initially unresponsive to cisplatin or become so during treatment. In this review, some strategies to overcome this problem are discussed. Among these are combination with the differentiation inducing agent, retinoic acid, combination with radiotherapy, and the use of hyperthermia.

Originele taal-2	Engels
Pagina's (van-tot)	388-393
Aantal pagina's	6
Tijdschrift	Clinical Oncology
Volume	4
Nummer van het tijdschrift	6
DOI's	https://doi.org/10.1016/S0936-6555(05)81134-3
Status	Gepubliceerd - 1992
Extern gepubliceerd	Ja

Toegang tot document

10.1016/S0936-6555(05)81134-3

Citeer dit

@article{7e1ab08569eb4c128317aa029fd13ad7,

title = "Combination therapy with cisplatin: Modulation of activity and tumour sensitivity",

abstract = "Although cisplatin is applied with success in clinical oncology, this success is limited because some cancers are initially unresponsive to cisplatin or become so during treatment. In this review, some strategies to overcome this problem are discussed. Among these are combination with the differentiation inducing agent, retinoic acid, combination with radiotherapy, and the use of hyperthermia.",

keywords = "Chemoradiotherapy, Cisplatin, Differentiation induction, Hyperthermia, Retinoids",

author = "Guchelaar, {H. J.} and Uges, {D. R.A.} and {de Vries}, {E. G.E.} and Oosterhuis, {J. W.} and Mulder, {N. H.}",

year = "1992",

doi = "10.1016/S0936-6555(05)81134-3",

language = "English",

volume = "4",

pages = "388--393",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier Ltd.",

number = "6",

}

TY - JOUR

T1 - Combination therapy with cisplatin

T2 - Modulation of activity and tumour sensitivity

AU - Guchelaar, H. J.

AU - Uges, D. R.A.

AU - de Vries, E. G.E.

AU - Oosterhuis, J. W.

AU - Mulder, N. H.

PY - 1992

Y1 - 1992

N2 - Although cisplatin is applied with success in clinical oncology, this success is limited because some cancers are initially unresponsive to cisplatin or become so during treatment. In this review, some strategies to overcome this problem are discussed. Among these are combination with the differentiation inducing agent, retinoic acid, combination with radiotherapy, and the use of hyperthermia.

AB - Although cisplatin is applied with success in clinical oncology, this success is limited because some cancers are initially unresponsive to cisplatin or become so during treatment. In this review, some strategies to overcome this problem are discussed. Among these are combination with the differentiation inducing agent, retinoic acid, combination with radiotherapy, and the use of hyperthermia.

KW - Chemoradiotherapy

KW - Cisplatin

KW - Differentiation induction

KW - Hyperthermia

KW - Retinoids

UR - http://www.scopus.com/inward/record.url?scp=0026948534&partnerID=8YFLogxK

U2 - 10.1016/S0936-6555(05)81134-3

DO - 10.1016/S0936-6555(05)81134-3

M3 - Review article

C2 - 1340781

AN - SCOPUS:0026948534

SN - 0936-6555

VL - 4

SP - 388

EP - 393

JO - Clinical Oncology

JF - Clinical Oncology

IS - 6

ER -

Combination therapy with cisplatin: Modulation of activity and tumour sensitivity

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit